Cas:2673-72-5 D-erythro-Sphingosine hydrochloride manufacturer & supplier

We serve Chemical Name:D-erythro-Sphingosine hydrochloride CAS:2673-72-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

D-erythro-Sphingosine hydrochloride

Chemical Name:D-erythro-Sphingosine hydrochloride
CAS.NO:2673-72-5
Synonyms:d-sphingosine hcl
Molecular Formula:C18H38ClNO2
Molecular Weight:335.95300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:66.48000
Exact Mass:335.25900
LogP:5.42650

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like d-sphingosine hcl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,d-sphingosine hcl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,d-sphingosine hcl Use and application,d-sphingosine hcl technical grade,usp/ep/jp grade.


Related News: Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days. D-erythro-Sphingosine hydrochloride manufacturer A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. D-erythro-Sphingosine hydrochloride supplier This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy. D-erythro-Sphingosine hydrochloride vendor Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. D-erythro-Sphingosine hydrochloride factory Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.